CROSSJECT (EPA:ALCJ) | WebDisclosure

Basculer en Français

9774	Companies
195581	Keywords
126571	Articles
103975	Press releases

Home
Companies
CROSSJECT

PRESS RELEASE

published on 09/22/2025 at 07:30, 4 months 8 days ago

CROSSJECT Secures Additional BARDA Funding for the Progressive Developmental and FDA Authorization of the ZEPIZURE® (ZENEO® Midazolam)
CROSSJECT secures $11.3 million BARDA funding for ZEPIZURE® development towards FDA authorization. Advances include validation batches and facility audit completion

BARDA Funding Crossject FDA Authorization ZEPIZURE Development Emergency Auto-injectors
PRESS RELEASE

published on 09/22/2025 at 07:30, 4 months 8 days ago

CROSSJECT obtient un financement supplémentaire de la BARDA pour soutenir le développement et l'autorisation par la FDA de ZEPIZURE®
CROSSJECT obtient un financement supplémentaire de 11,3 millions de dollars de la BARDA pour le développement de ZEPIZURE® approuvé par la FDA

FDA Financement Crossject ZEPIZURE BARDA
BRIEF

published on 07/01/2025 at 07:35, 6 months 29 days ago

Change of liquidity contract for CROSSJECT

Liquidity Euronext Pharmaceutical Contract Crossject
BRIEF

published on 07/01/2025 at 07:35, 6 months 29 days ago

Changement de contrat de liquidité pour CROSSJECT

Contrat Euronext Liquidité Pharmaceutique Crossject
PRESS RELEASE

published on 07/01/2025 at 07:30, 6 months 29 days ago

CROSSJECT annonce la cessation et la mise en œuvre d’un nouveau contrat de liquidité
CROSSJECT annonce la cessation et la mise en œuvre d’un nouveau contrat de liquidité avec Rothschild Martin Maurel pour favoriser la liquidité des transactions. Détails du contrat et impacts sur le marché réglementé d'Euronext

Contrat De Liquidité Rothschild Martin Maurel Euronext Crossject ZENEO®
BRIEF

published on 06/24/2025 at 19:05, 7 months 5 days ago

CROSSJECT obtient une augmentation de capital de 5,7 millions d'euros

Augmentation De Capital Soumission À La FDA ZEPIZURE® Gemmes Venture Vatel Capital
BRIEF

published on 06/24/2025 at 19:05, 7 months 5 days ago

CROSSJECT Secures €5.7 Million in Capital Increase

Capital Increase FDA Submission ZEPIZURE® Gemmes Venture Vatel Capital
PRESS RELEASE

published on 06/24/2025 at 19:00, 7 months 5 days ago

CROSSJECT announces a successful capital increase of €5.7 million following full exercise of the extension clause
CROSSJECT successfully completes a capital increase of €5.7 million through preferential subscription rights, benefiting from new investor support and Gemmes Venture, to advance ZEPIZURE® development

Capital Increase Crossject ZEPIZURE® Gemmes Venture Vatel Capital
PRESS RELEASE

published on 06/24/2025 at 19:00, 7 months 5 days ago

CROSSJECT annonce le vif succès de son augmentation de capital portée à 5,7 millions d’euros après exercice intégral de la clause d’extension
CROSSJECT annonce le vif succès de son augmentation de capital à 5,7 millions d’euros après exercice intégral de la clause d’extension pour ZEPIZURE®

Financement Augmentation De Capital Pharmaceutique Crossject ZEPIZURE
BRIEF

published on 06/11/2025 at 07:35, 7 months 19 days ago

CROSSJECT advances in the development of ZEPIZURE® Junior for children

Epilepsy Pediatrics Crossject Auto-injector ZEPIZURE Junior

Accesswire

Published on 01/30/2026 at 08:00, 19 minutes ago

Troubadour Resources Intercepts Target Mineralization Near Surface during Phase 1 of the Multi-Phase Drill Program at Senneville Gold-Silver-Copper Property
Published on 01/30/2026 at 02:15, 6 hours 4 minutes ago

Canex Metals Announces Success of Gold Basin Take-Over Bid, Extension of the Partial Revocation of the Cease-Trade Order Imposed on Gold Basin, Waiver of All Remaining Conditions, Initiation of the Share Take Up Process, and Mandatory 10-Day Extension
Published on 01/30/2026 at 00:00, 8 hours 19 minutes ago

LIR Life Sciences Reports Positive Interim Preclinical Results from Comparative Animal Study of Novel CPP-Enabled Transdermal Delivery of GLP/GIP-Based Therapies
Published on 01/29/2026 at 23:00, 9 hours 19 minutes ago

PPX Mining Announces Filing of 2025 Audited Financial Statements and MD&A
Published on 01/29/2026 at 18:45, 13 hours 34 minutes ago

Silver Spruce Appoints Vice-President of Exploration

View all ACCESSWIRE

EQS Group

Published on 01/30/2026 at 08:00, 19 minutes ago

Ørsted to present its annual report for 2025 on February 6
Published on 01/30/2026 at 08:00, 19 minutes ago

Transaction in Own Shares
Published on 01/30/2026 at 08:00, 19 minutes ago

Aquis Stock Exchange: Admission to trading
Published on 01/30/2026 at 07:29, 50 minutes ago

Consolidated profit (excluding Russia) above 1.4 billion euros
Published on 01/30/2026 at 07:00, 1 hour 19 minutes ago

Unbroken record series with high revenue momentum for cloud and subscriptions – 20th record year in a row for revenue and earnings

Les Echos

Published on 01/30/2026 at 08:00, 19 minutes ago

AMA: 4th Quarter & FY 2025 Revenues
Published on 01/30/2026 at 08:00, 19 minutes ago

AMA : Chiffre d'affaires du 4ème trimestre et de l'année 2025
Published on 01/29/2026 at 18:30, 13 hours 49 minutes ago

ALPOU - Groupe POULAILLON chiffre d'affaires trimestriel T1 2025-2026 et Focus sur les activités
Published on 01/29/2026 at 18:07, 14 hours 12 minutes ago

CDA - Mise à disposition de l'URD 2025
Published on 01/29/2026 at 18:00, 14 hours 19 minutes ago

GUILLEMOT CORPORATION: FULL-YEAR 2025 CONSOLIDATED TURNOVER UP 2%

View all LES ECHOS COMFI WIRE